Analgesics Global Market Report 2025

Description

Analgesics are medications used to alleviate pain, including conditions such as musculoskeletal pain, surgical pain, trauma-induced pain, and cancer-related pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone.

The main types of analgesics are non-opioids and opioids. Non-opioid analgesics are pain relievers available over-the-counter (OTC) and by prescription. They are increasingly promoted as a desirable, safe, and effective first-line therapeutic option in various clinical settings for managing mild to severe acute and chronic pain. Analgesics come in different forms, including prescription analgesics and over-the-counter (OTC) analgesics, with various routes of administration such as oral, intravenous, rectal, transdermal, and topical. They are used both internally (internal analgesics) and externally (external analgesics) and are distributed through channels such as hospital pharmacies, retail pharmacies, and drug stores.

The analgesics market research report is one of a series of new reports from The Business Research Company that provides analgesics market statistics, including analgesics industry global market size, regional shares, competitors with an analgesics market share, detailed analgesics market segments, market trends, and opportunities, and any further data you may need to thrive in the analgesics industry. This analgesics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The analgesics market size has grown steadily in recent years. It will grow from $109.97 billion in 2024 to $113.96 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to alternative therapies impact, safety and efficacy studies, pain prevalence, marketing and promotion, economic factors.

The analgesics market size is expected to see steady growth in the next few years. It will grow to $129.46 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to pain management alternatives, market competition, consumer health awareness, demographic shifts, rising chronic diseases. Major trends in the forecast period include personalized medicine, non-opioid alternatives, CBD and cannabinoids usage, targeted pain management, accessibility and affordability.

The analgesics market is experiencing significant growth, driven by a notable increase in the prevalence of chronic diseases. Chronic diseases, also known as noncommunicable diseases (NCDs), develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral factors. According to a September 2022 report from the World Health Organization (WHO), NCDs account for 74% of global fatalities, totaling 41 million deaths annually. These diseases result in 17 million premature deaths each year before the age of 70, with 86% occurring in low- and middle-income nations. The escalating prevalence of chronic diseases is a key factor fueling the expansion of the analgesics market as these drugs effectively treat and alleviate severe pain associated with various medical conditions.

The increase in healthcare expenditures is anticipated to drive the growth of the analgesics market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning, nutrition programs, and emergency assistance with a health focus. Rising healthcare spending supports research and development within the pharmaceutical industry for the creation of new and enhanced analgesic medications. For example, in May 2024, the Office for National Statistics, a UK government department, reported that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023. Consequently, the rise in healthcare expenditures is fueling the growth of the analgesics market.

Companies in the analgesics market are strategically investing to foster growth. Leading manufacturers are channeling investments into clinical-stage companies to enhance their market position and gain a competitive edge. In January 2022, Concentric Analgesics, Inc., secured $20 million in convertible note financing to advance the Phase 3 development of Vocacapsaicin, its lead product candidate for post-surgical pain. Such investments allow companies to expand geographically and attain specialized expertise in research and development, strengthening their overall competitiveness.

Leading companies in the analgesic market are increasingly concentrating on introducing combination analgesics to strengthen their competitive position. Combination analgesics contain a blend of two or more pain-relieving (analgesic) drugs, often designed to provide enhanced pain relief by targeting pain through multiple mechanisms. For instance, in February 2024, UK-based Hikma Pharmaceuticals plc launched COMBOGESIC IV (acetaminophen and ibuprofen) in the United States. This intravenous formulation combines acetaminophen (paracetamol) and ibuprofen, offering dual-action pain relief through the analgesic and anti-inflammatory properties of both drugs. Developed as a non-opioid alternative for pain management, COMBOGESIC IV delivers 1,000 mg of acetaminophen and 300 mg of ibuprofen, providing an effective option amid rising opioid concerns. This formulation offers over twice the pain relief of each component alone, with a quicker onset and a favorable safety profile.

In December 2023, Wellnex Life Limited, an Australian company in the health and wellness sector, acquired Pain Away Ltd. for $22 million. This acquisition aligns with Wellnex's long-term strategy to own brands in stable healthcare segments, strengthening its market position. Pain Away Ltd., a U.S.-based company, specializes in developing and distributing topical pain relief products.

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the analgesics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The analgesics market consists of sales of codeine, hydrocodone, oxycodone, and methadone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Analgesics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on analgesics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for analgesics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The analgesics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Non-opioids; Opioids
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores
3) By Application: Internal Analgesics; External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Acetaminophen (Paracetamol); Salicylates
2) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medley Pharmaceuticals Limited; AbbVie Inc.; Bayer HealthCare Pharmaceuticals LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26108

1. Executive Summary

2. Analgesics Market Characteristics

3. Analgesics Market Trends And Strategies

4. Analgesics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Analgesics Growth Analysis And Strategic Analysis Framework

5.1. Global Analgesics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Analgesics Market Growth Rate Analysis
5.4. Global Analgesics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Analgesics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Analgesics Total Addressable Market (TAM)

6. Analgesics Market Segmentation

6.1. Global Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-opioids
Opioids
6.2. Global Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Drug Stores
6.3. Global Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Internal Analgesics
External Analgesics
6.4. Global Analgesics Market, Sub-Segmentation Of Non-Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Acetaminophen (Paracetamol)
Salicylates
6.5. Global Analgesics Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Opioids
Semi-Synthetic Opioids
Synthetic Opioids

7. Analgesics Market Regional And Country Analysis

7.1. Global Analgesics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Analgesics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Analgesics Market

8.1. Asia-Pacific Analgesics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Analgesics Market

9.1. China Analgesics Market Overview
9.2. China Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Analgesics Market

10.1. India Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Analgesics Market

11.1. Japan Analgesics Market Overview
11.2. Japan Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Analgesics Market

12.1. Australia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Analgesics Market

13.1. Indonesia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Analgesics Market

14.1. South Korea Analgesics Market Overview
14.2. South Korea Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Analgesics Market

15.1. Western Europe Analgesics Market Overview
15.2. Western Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Analgesics Market

16.1. UK Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Analgesics Market

17.1. Germany Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Analgesics Market

18.1. France Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Analgesics Market

19.1. Italy Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Analgesics Market

20.1. Spain Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Analgesics Market

21.1. Eastern Europe Analgesics Market Overview
21.2. Eastern Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Analgesics Market

22.1. Russia Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Analgesics Market

23.1. North America Analgesics Market Overview
23.2. North America Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Analgesics Market

24.1. USA Analgesics Market Overview
24.2. USA Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Analgesics Market

25.1. Canada Analgesics Market Overview
25.2. Canada Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Analgesics Market

26.1. South America Analgesics Market Overview
26.2. South America Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Analgesics Market

27.1. Brazil Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Analgesics Market

28.1. Middle East Analgesics Market Overview
28.2. Middle East Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Analgesics Market

29.1. Africa Analgesics Market Overview
29.2. Africa Analgesics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Analgesics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Analgesics Market Competitive Landscape And Company Profiles

30.1. Analgesics Market Competitive Landscape
30.2. Analgesics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medley Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer HealthCare Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis

31. Analgesics Market Other Major And Innovative Companies

31.1. Novartis International AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb Co.
31.4. AstraZeneca Plc.
31.5. Abbott Laboratories
31.6. GlaxoSmithKline plc
31.7. Takeda Pharmaceutical company Limited
31.8. Eli Lilly and Company
31.9. Reckitt Benckiser Group plc
31.10. Viatris Inc.
31.11. Teva Pharmaceuticals Industries Ltd.
31.12. Sun Pharmaceutical Industries Limited
31.13. Purdue Pharma L.P
31.14. Cipla Limited
31.15. Allergan Inc.

32. Global Analgesics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Analgesics Market

34. Recent Developments In The Analgesics Market

35. Analgesics Market High Potential Countries, Segments and Strategies

35.1 Analgesics Market In 2029 - Countries Offering Most New Opportunities
35.2 Analgesics Market In 2029 - Segments Offering Most New Opportunities
35.3 Analgesics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer